1801342-60-8: A Deep Dive This piece provides a detailed investigation into cemiplimab, a significant monoclonal therapeutic targeting PD-1. Development surrounding this drug has generated growing interest, particularly due to its utility in treating various malignancies. We will discuss its how it works, study findings, advantages and limitations